EXPD vs PSTV · P/E 26, rev $6.29B vs P/E 0.2, rev $5.8M
Expeditors International of Washington, Inc. (EXPD) versus Plus Therapeutics Inc (PSTV) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
Latest reported EXPD revenue for 2026-06-30 was $6.29B. Net income was $495.8M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Not investment advice. Open the EXPD and PSTV stock pages for the full models.
Not investment advice.